NCT01287104
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +26 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,082 public trials
2,050 recruiting studies
Lymphoproliferative Disorders trial results
NCT03042585
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Patrick Stiff, MD Maywood, Illinois, United States
NCT00474929
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +44 more
- Locations
-
- Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
Completed
Elotuzumab Safety Surveillance In Japanese Patients With Relapse Or Refractory Multiple Myeloma
NCT02976493
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Local Institution Shinjuku-ku, Tokyo, Japan
Completed
Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma
NCT00937183
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology - Warsaw Warsaw, Poland
Completed
A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
NCT02272777
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +16 more
- Locations
-
- Novartis Investigative Site Guangzhou, Guangdong, China
- Novartis Investigative Site Guangzhou, Guangdong, China
- Novartis Investigative Site Wuhan, Hubei, China
- Novartis Investigative Site Nanjing, Jiangsu, China
Completed
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)
NCT01675102
- Conditions
- CLL, Chromosome 17 deletion, Chronic Disease, +15 more
- Locations
-
- Rigshospitalitet Copenhagen, Denmark
- University Central Hospital Helsinki, Finland
- Universitaetsklinikum Dresden, Germany
- University Hospital Eppendorf Hamburg, Germany
NCT02556892
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Fukuoka, Japan
- Hiroshima, Japan
- Isehara, Japan
- Kobe, Japan
NCT00438802
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +14 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
NCT01676831
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States